Artiam Bio

Curated by Signal

Developer of cannabinoid-derived therapeutics for multiple diseases

Overview

Developer of cannabinoid-derived therapeutics for multiple diseases. It offers type 1 cannabinoid receptor (CB1) antagonists to treat non-alcoholic steatohepatitis, Prader Willi Syndrome, and Cannabis Use Disorder.

Key facts

Founded: 2020
Headquarters: Morrisville, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Pathomics.ai
Provider of artificial intelligence based pathomics solutions for cancer diagnosis and patient management
Health TechnologyHouston, United States
K4Connect
Software platform to connect devices
Health TechnologyRaleigh, United States
AGL
Online pharmacy for cannabis medical and recreational products
Health TechnologyWest Haven, United States

About Artiam Bio

What does Artiam Bio do?

Developer of cannabinoid-derived therapeutics for multiple diseases.

Where is Artiam Bio headquartered?

Artiam Bio is headquartered in Morrisville, United States.

When was Artiam Bio founded?

Artiam Bio was founded in 2020.

Which sector is Artiam Bio in?

Artiam Bio operates in Health Technology.

Who are Artiam Bio's competitors?

Companies similar to Artiam Bio include Pathomics.ai, K4Connect, and AGL.